Human immunodeficiency virus (HIV) and stroke: Targets for intervention

Infectious Disorders - Drug Targets

Volumn 10, Issue 2, 2010, Pages 76-83

  Connor, Myles ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ATHEROSCLEROSIS; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; DISEASE ASSOCIATION; ENDOTHELIAL DYSFUNCTION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; RISK FACTOR; VASCULITIS;

EID: 77958054760     PISSN: 18715265     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152610790963483     Document Type: Article

References (76)

1. Pinto, A. N. AIDS/HIV Infection and Cerebrovascular Disease. Semin. Cerebrovasc. Dis. Stroke, 2005, 5, 40-46.
2. Cole, J. W.; Pinto, A. N.; Hebel, J. R.; Buchholz, D. W.; Earley, C. J.; Johnson, C. J.; Macko, R. F.; Price, T. R.; Sloan, M. A.; Stern, B. J.; Wityk, R. J.; Wozniak, M. A.; Kittner, S. J. Acquired immunodeficiency syndrome and the risk of stroke. Stroke, 2004, 35(1), 51-56.
3. Berger, J. R. AIDS and stroke risk. Lancet Neurol., 2004, 3(4), 206-207.
4. Kumwenda, J. J.; Mateyu, G.; Kampondeni, S.; van Dam, A. P.; van Lieshout, L.; Zijlstra, E. E. Differential diagnosis of stroke in a setting of high HIV prevalence in Blantyre, Malawi. Stroke, 2005, 36(5), 960-964.
5. Ortiz, G.; Koch, S.; Romano, J. G.; Forteza, A. M.; Rabinstein, A. A. Mechanisms of ischemic stroke in HIV-infected patients. Neurology, 2007, 68(16), 1257-1261.
6. Connor, M. D.; Lammie, G. A.; Bell, J. E.; Warlow, C. P.; Simmonds, P.; Brettle, R. D. Cerebral infarction in adult AIDS patients: observations from the Edinburgh HIV Autopsy Cohort. Stroke, 2000, 31, 2117-2126.
7. Rabinstein, A. A. Stroke in HIV-infected patients: a clinical perspective. Cerebrovasc. Dis., 2003, 15(1-2), 37-44.
8. Evers, S.; Nabavi, D.; Rahmann, A.; Heese, C.; Reichelt, D.; Husstedt, I. W. Ischaemic cerebrovascular events in HIV infection: a cohort study. Cerebrovasc. Dis., 2003, 15, 199-205.
9. Mochan, A.; Modi, G.; Modi, M. M. Stroke in black South African HIV-positive patients: a prospective analysis. Stroke, 2003, 34(1), 10-5.
10. Hoffmann, M.; Berger, J. R.; Nath, A.; Rayens, M. Cerebrovascular disease in young, HIV-infected, black Africans in the KwaZulu Natal province of South Africa. J. Neurovirol., 2000, 6(3), 229-236.
11. Tipping, B.; de Villiers, L.; Wainwright, H.; Candy, S.; Bryer, A. Stroke in patients with human immunodeficiency virus infection. J. Neurol. Neurosurg. Psychiatry, 2007, 78(12), 1320-4.
12. Chetty, R. Vasculitides associated with HIV infection. J. Clin. Pathol., 2001, 54(4), 275-278.
13. Nair, R.; Robbs, J. V.; Chetty, R.; Naidoo, N. G.; Woolgar, J. Occlusive arterial disease in HIV-infected patients: a preliminary report. Eur. J. Vasc. Endovasc. Surg., 2000, 20(4), 353-357.
14. Connor, M. Stroke in patients with human immunodeficiency virus infection. J. Neurol. Neurosurg. Psychiatry, 2007, 78(12), 1291.
15. Mizusawa, H.; Hirano, A.; Llena, J. F.; Shintaku, M. Cerebrovascular lesions in acquired immune deficiency syndrome (AIDS). Acta Neuropathol., 1988, 76(5), 451-7.
16. Chetty, R.; Batitang, S.; Nair, R. Large artery vasculopathy in HIVpositive patients: another vasculitic enigma. Hum Pathol., 2000, 31(3), 374-379.
17. Dubrovsky, T.; Curless, R.; Scott, G.; Chaneles, M.; Post, M. J. D.; Altman, N.; Petito, C. K.; Start, D.; Wood, C. Cerebral aneurysmal arteriopathy in childhood AIDS. Neurology, 1998, 51(2), 560-565.
18. Park, Y. D.; Belman, A. L.; Kim, T. S.; Kure, K.; Llena, J. F.; Lantos, G.; Bernstein, L.; Dickson, D. W. Stroke in pediatric acquired immunodeficiency syndrome. Ann. Neurol., 1990, 28(3), 303-311.
19. Tipping, B.; de Villiers, L.; Candy, S.; Wainwright, H. Stroke caused by human immunodeficiency virus-associated intracranial large-vessel aneurysmal vasculopathy. Arch. Neurol., 2006, 63(11), 1640-1642.
20. Modi, G.; Ranchod, K.; Modi, M.; Mochan, A. Human immunodeficiency virus associated intracranial aneurysms: report of three adult patients with an overview of the literature. J. Neurol. Neurosurg. Psychiatry, 2008, 79(1), 44-46.
21. O'Charoen, P.; Hesselink, J. R.; Healy, J. F. Cerebral aneurysmal arteriopathy in an adult patient with acquired immunodeficiency syndrome. Am. J. Neuroradiol., 2007, 28(5), 938-939.
22. Kossorotoff, M.; Touze, E.; Godon-Hardy, S.; Serre, I.; Mateus, C.; Mas, J.-L.; Zuber, M. Cerebral vasculopathy with aneurysm formation in HIV-infected young adults. Neurology, 2006, 66(7), 1121-1122.
23. Mazzoni, P.; Chiriboga, C. A.; Millar, W. S.; Rogers, A. Intracerebral aneurysms in human immunodeficiency virus infection: case report and literature review. Pediatr. Neurol., 2000, 23(3), 252-255.
24. Kure, K.; Park, Y. D.; Kim, T. S.; Lyman, W. D.; Lantos, G.; Lee, S.; Cho, S.; Belman, A. L.; Weidenheim, K. M.; Dickson, D. W. Immunohistochemical localization of an HIV epitope in cerebral aneurysmal arteriopathy in pediatric acquired immunodeficiency syndrome (AIDS). Pediatr. Pathol., 1989, 9(6), 655-667.
25. Monsuez, J. J.; Charniot, J. C.; Escaut, L.; Teicher, E.; Wyplosz, B.; Couzigou, C.; Vignat, N. l.; Vittecoq, D. HIV-associated vascular diseases: structural and functional changes, clinical implications. Int. J. Cardiol., 2009, 133(3), 293-306.
26. Krizanac-Bengez, L.; Mayberg, M. R.; Janigro, D. The cerebral vasculature as a therapeutic target for neurological disorders and the role of shear stress in vascular homeostasis and pathophysiology. Neurol. Res., 2004, 26(8), 846-853.
27. Guillevin, L. Vasculitides in the context of HIV infection. AIDS, 2008, 22 (Suppl 3) S27-S33.
28. Volberding, P. A.; Murphy, R. L.; Barbaro, G.; Barbarini, G.; Bruno, R.; Cirelli, A.; Currie, P. F.; Di Lorenzo, G.; Fantoni, M.; Filiced, G.; Galli, M.; Grisorio, B.; Moroni, M.; Recusani, F.; Sacchi, P.; Scevola, D.; Stein, J. H.; Torre, D.; Vittecoq, D. The pavia consensus statement. AIDS, 2003, 17(Suppl 1) S170-S179.
29. Johnson, R. M.; Barbarini, G.; Barbaro, G. Kawasaki-like syndromes and other vasculitic syndrome in HIV-infected patients. AIDS, 2003, 17 (Suppl 1), S77-S82.
30. Calabrese, L. H.; Mallek, J. A. Primary angiitis of the central nervous system. Report of 8 new cases, review of the literature, and proposal for diagnostic criteria. Medicine, (Baltimore) 1988, 67(1), 20-39.
31. Birnbaum, J.; Hellmann, D. B. Primary angiitis of the central nervous system. Arch. Neurol., 2009, 66(6), 704-709.
32. Tran Dinh, Y. R.; Mamo, H.; Cervoni, J.; Caulin, C.; Saimot, A. C. Disturbances in the cerebral perfusion of human immune deficiency virus-1 seropositive asymptomatic subjects: a quantitative tomography study of 18 cases. J. Nucl. Med., 1990, 31(10), 1601-1607.
33. Brilla, R.; Nabavi, D. G.; Schulte-Altedorneburg, G.; Kemeny, V.; Reichelt, D.; Evers, S.; Schiemann, U.; Husstedt, I. W. Cerebral vasculopathy in HIV infection revealed by transcranial Doppler: A pilot study. Stroke, 1999, 30(4), 811-813.
34. Emsley, H. C.; Tyrrell, P. J. Inflammation and infection in clinical stroke. J. Cereb. Blood Flow Metab., 2002, 22(12), 1399-1419.
35. Lindsberg, P. J.; Grau, A. J. Inflammation and infections as risk factors for ischemic stroke. Stroke, 2003, 34(10), 2518-2532.
36. Emsley, H. C.; Hopkins, S. J. Acute ischaemic stroke and infection: recent and emerging concepts. Lancet Neurol., 2008, 7(4), 341-353.
37. Moses, A. V.; Bloom, F. E.; Pauza, C. D.; Nelson, J. A. Human immunodeficiency virus infection of human brain capillary endothelial cells occurs via a CD4/galactosylceramide-independent mechanism. Proc. Natl. Acad. Sci. USA, 1993, 90(22), 10474-10478.
38. Poland, S. D.; Rice, G. P.; Dekaban, G. A. HIV-1 infection of human brain-derived microvascular endothelial cells in vitro. J. Acquir. Immune. Defic. Syndr. Hum. Retrovirol., 1995, 8(5), 437-445.
39. Ades, E. W.; Nicholson, J. K.; Browning, S. W.; Comans, T. W. Inability of human immunodefiency virus to infect human microvascular endothelial cells. Pathobiology, 1992, 60(6), 330-331.
40. Ades, E. W.; Comans, T. W.; Nicholson, J. K.; Browning, S. W. Lack of evidence that human immunodeficiency virus can infect human endothelial cells in vitro. J. Acquir. Immune. Defic. Syndr., 1993, 6(1), 104.
41. Liu, N. Q.; Lossinsky, A. S.; Popik, W.; Li, X.; Gujuluva, C.; Kriederman, B.; Roberts, J.; Pushkarsky, T.; Bukrinsky, M.; Witte, M.; Weinand, M.; Fiala, M. Human immunodeficiency virus type 1 enters brain microvascular endothelia by macropinocytosis dependent on lipid rafts and the mitogen-activated protein kinase signaling pathway. J. Virol., 2002, 76(13), 6689-6700.
42. An, S. F.; Groves, M.; Gray, F.; Scaravilli, F. Early entry and widespread cellular involvement of HIV-1 DNA in brains of HIV-1 positive asymptomatic individuals. J. Neuropathol. Exp. Neurol., 1999, 58(11), 1156-1162.
43. An, S. F.; Groves, M.; Martinian, L.; Kuo, L. T.; Scaravilli, F. Detection of infectious agents in brain of patients with acute hemorrhagic leukoencephalitis. J. Neurovirol., 2002, 8(5), 439-446.
44. Bagasra, O.; Lavi, E.; Bobroski, L.; Khalili, K.; Pestaner, J. P.; Tawadros, R.; Pomerantz, R. J. Cellular reservoirs of HIV-1 in the central nervous system of infected individuals: identification by the combination of in situ polymerase chain reaction and immunohistochemistry. AIDS, 1996, 10(6), 573-585.
45. Kline, E. R.; Sutliff, R. L. The roles of HIV-1 proteins and antiretroviral drug therapy in HIV-1 associated endothelial dysfunction. J. Investig. Med., 2008, 56(5), 752-769.
46. Maggi, P.; Maserati, R.; Antonelli, G. Atherosclerosis in HIV patients: a new face for an old disease? AIDS Rev., 2006, 8(4), 204-209.
47. Oliviero, U.; Bonadies, G.; Apuzzi, V.; Foggia, M.; Bosso, G.; Nappa, S.; Valvano, A.; Leonardi, E.; Borgia, G.; Castello, G.; Napoli, R.; Sacca, L. Human immunodeficiency virus per se exerts atherogenic effects. Atherosclerosis, 2009, 204(2), 586-589.
48. Passalaris, J. D.; Sepkowitz, K. A.; Glesby, M. J. Coronary artery disease and human immunodefiency virus infection. Clin. Infect. Dis., 2000, 31(3), 787-797.
49. Feingold, K. R.; Krauss, R. M.; Pang, M.; Doerrler, W.; Jensen, P.; Grunfeld, C. The hypertriglyceridemia of acquired immunodeficiency syndrome is associated with an increased prevalence of low density lipoprotein subclass pattern B. J. Clin. Endocrinol. Metab., 1993, 76(6), 1423-1427.
50. Grinspoon, S.; Carr, A. N. Cardiovascular risk and body fat abnormalities in HIV-infected adults. N. Engl. J. Med., 2005, 352(1), 48-62.
51. Rasheed, S.; Yan, J. S.; Lau, A.; Chan, A. S. HIV replication enhances production of free fatty acids, low density lipoproteins and many key proteins involved in lipid metabolism: a proteomics study. PLoS One, 2008, 3(8), e3003.
52. Palella, F. J.; Delaney, K. M.; Moorman, A. C.; Loveless, M. O.; Fuhrer, J.; Satten, G. A.; Aschman, D. J.; Holmberg, S. D.; The HIV Outpatient Study Investigators. Declining morbidity and mortality among patients with advanced human immunodefiency virus infection. N. Engl. J. Med., 1998, 338(13), 853-860.
53. Corral, I.; Quereda, C.; Moreno, A.; Perez-Elias, M. J.; Dronda, F.; Casado, J. L.; Muriel, A.; Masjuan, J.; Alonso-de-Lecinana, M.; Moreno, S. Cerebrovascular ischemic events in HIV-1-infected patients receiving highly active antiretroviral therapy: incidence and risk factors. Cerebrovasc. Dis., 2009, 27(6), 559-563.
54. Ho, J. E.; Hsue, P. Y. Cardiovascular manifestations of HIV infection. Heart, 2009, 95(14), 1193-1202.
55. Calza, L.; Manfredi, R.; Pocaterra, D.; Chiodo, F. Risk of premature atherosclerosis and ischemic heart disease associated with HIV infection and antiretroviral therapy. J. Infect., 2008, 57(1), 16-32.
56. Carr, A.; Ory, D. Does HIV cause cardiovascular disease? PLoS Med., 2006, 3(11), e496.
57. Gaetano Donati, K.; Rabagliati, R.; Iacoviello, L.; Cauda, R. HIV infection, HAART, and endothelial adhesion molecules: current perspectives. Lancet Infect. Dis., 2004, 4(4), 213-222.
58. Bozzette, S. A.; Ake, C. F.; Tam, H. K.; Chang, S. W.; Louis, T. A. Cardiovascular and cerebrovascular events in patients treated for human immunodefiency virus infection. N. Engl. J. Med., 2003, 348(8), 702-710.
59. Mary-Krause, M.; Cotte, L.; Simon, A.; Partisani, M.; Costagliola, D. Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men. AIDS, 2003, 17(17), 2479-2486.
60. Currier, J. S.; Taylor, A.; Boyd, F.; Dezii, C. M.; Kawabata, H.; Burtcel, B.; Maa, J. F.; Hodder, S. Coronary heart disease in HIVinfected individuals. J. Acquir. Immune. Defic. Syndr., 2003, 33(4), 506-512.
61. DAD Study Group, Friis-Moller, N.; Reiss, P.; Sabin, C. A.; Weber, R.; Monforte, A.; El Sadr, W.; Thiebaut, R.; De Wit, S.; Kirk, O.; Fontas, E.; Law, M. G.; Phillips, A.; Lundgren, J. D. Class of antiretroviral drugs and the risk of myocardial infarction. N. Engl. J. Med., 2007, 356(17), 1723-1735.
62. Coplan, P. M.; Nikas, A.; Japour, A.; Cormier, K.; Maradit-Kremers, H.; Lewis, R.; Xu, Y.; DiNubile, M. J. Incidence of myocardial infarction in randomised clinical trials of protease inhibitor-based antiretroviral therapy: an analysis of four different protease inhibitors. AIDS Res. Hum. Retroviruses, 2003, 19(6), 449-455.
63. Iloeje, U. H.; Yuan, Y.; L'italien, G.; Mauskopf, J.; Holmberg, S. D.; Moorman, A. C.; Wood, K. C.; Moore, R. D. Protease inhibitor exposure and risk of cardiovascular disease in HIV-infected patients. HIV. Med., 2005, 6(1), 37-44.
64. Holmberg, S. D.; Moorman, A. C.; Williamson, J. M.; Tong, T. C.; Ward, D. J.; Wood, K. C.; Greenberg, A. E.; Janssen, R. S. Protease inhibitors and cardiovascular outcomes in patients with HIV-1. Lancet, 2002, 360(9347), 1747-1748.
65. Rickerts, V.; Brodt, H.; Staszewski, S.; Stille, W. Incidence of myocardial infarctions in HIV-infected patients between 1983 and 1998: the Frankfurt HIV-cohort study. Eur. J. Med. Res., 2000, 5(8), 329-333.
66. Klein, D.; Hurley, L. B.; Quesenberry, C. P., Jr.; Sidney, S. Do protease inhibitors increase the risk for coronary heart disease in patients with HIV-1 infection? J. Acquir. Immune. Defic. Syndr., 2002, 30(5), 471-477.
67. Obel, N.; Thomsen, H. F.; Kronborg, G.; Larsen, C. S.; Hildebrandt, P. R.; Sorensen, H. T.; Gerstoft, J. Ischemic heart disease in HIV-infected and HIV-uninfected individuals: a population-based cohort study. Clin. Infect. Dis., 2007, 44(12), 1625-1631.
68. Triant, V. A.; Lee, H.; Hadigan, C.; Grinspoon, S. K. Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. J. Clin. Endocrinol. Metab., 2007, 92(7), 2506-2512.
69. Kaplan, R. C.; Kingsley, L. A.; Sharrett, A. R.; Li, X.; Lazar, J.; Tien, P. C.; Mack, W. J.; Cohen, M. H.; Jacobson, L.; Gange, S. J. Ten-year predicted coronary heart disease risk in HIV-infected men and women. Clin. Infect. Dis., 2007, 45(8), 1074-1081.
70. Barbaro, G.; Di Lorenzo, G.; Cirelli, A.; Grisorio, B.; Lucchini, A.; Hazra, C.; Barbarini, G. An open-label, prospective, observational study of the incidence of coronary artery disease in patients with HIV infection receiving highly active antiretroviral therapy. Clin. Ther., 2003, 25(9), 2405-2418.
71. Hsue, P. Y.; Waters, D. D. What a cardiologist needs to know about patients with human immunodeficiency virus infection. Circulation, 2005, 112(25), 3947-3957.
72. Nieuwhof, C. M. G.; Damoiseaux, J.; Cohen Tervaert, J. W. Successful treatment of cerebral vasculitis in an HIV-positive patient with anti-CD25 treatment. Ann. Rheum. Dis., 2006, 65(12), 1677-1678.
73. The Strategies for Management of Antiretroviral Therapy (SMART) Study Group. CD4 count-guided interruption of antiretroviral treatment. N. Eng. J. Med., 2006, 355(22), 2283-2296.
74. Buchbinder, S. Highlights of the 15th Conference on Retroviruses and Opportunistic Infections. HIV testing and prevention strategies. Top. HIV. Med., 2008, 16(1), 9-14.
75. Stein, J. H.; Hadigan, C. M.; Brown, T. T.; Chadwick, E.; Feinberg, J.; Friis-Moller, N.; Ganesan, A.; Glesby, M. J.; Hardy, D.; Kaplan, R. C.; Kim, P.; Lo, J.; Martinez, E.; Sosman, J. M. Prevention strategies for cardiovascular disease in HIV-infected patients. Circulation, 2008, 118(2), e54-e60.
76. Grinspoon, S. K.; Grunfeld, C.; Kotler, D. P.; Currier, J. S.; Lundgren, J. D.; Dube, M. P.; Lipshultz, S. E.; Hsue, P. Y.; Squires, K.; Schambelan, M.; Wilson, P. W.; Yarasheski, K. E.; Hadigan, C. M.; Stein, J. H.; Eckel, R. H. State of the science conference: Initiative to decrease cardiovascular risk and increase quality of life for patients living with HIV/AIDS: executive summary. Circulation, 2008, 118(2), 198-210.